Soteropoulos Paula — SEC insider filings
SEC reporting owner CIK 1692444. 24 insider filings on record with FilingPulse; latest filed 2026-10-20.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2021-03-01 to 2026-10-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 11 filings — 53,771 shares, $2,796,461 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
- Largest priced transaction: sale of 27,594 shares @ $78.05 ($2,153,712) in Dianthus Therapeutics, Inc. /DE/, filed 2026-03-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | 7 | — | 3 legs · 28,792 sh · $2,252,894 | 10 |
| uniQure N.V. (QURE) | Director | 11 | — | 9 legs · 24,979 sh · $543,566 | 16 |
| Rallybio Corp (RLYB) | Director | 6 | — | — | 7 |
Insider filings — Soteropoulos Paula
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-20 | 4 | Rallybio Corp (RLYB) | Option exercise (M): 3,562 @ $2.38 · Option exercise (M): 3,562 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 6,090 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 599 @ $8.44 · Sale (S): 599 @ $85.47 · Option exercise (M): 599 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 599 @ $8.44 · Sale (S): 599 @ $80.11 · Option exercise (M): 599 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 27,594 @ $8.44 · Sale (S): 27,594 @ $78.05 · Option exercise (M): 27,594 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | uniQure N.V. (QURE) | Sale (S): 2,220 @ $5.14 | EDGAR |
| 2024-05-28 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2023-09-13 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2023-06-20 | 4 | uniQure N.V. (QURE) | Grant/award (A): 8,700 @ $0 · Sale (S): 2,275 @ $18.99 · Grant/award (A): 17,060 (derivative) @ $0 | EDGAR |
| 2023-05-19 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 15,490 (derivative) @ $0 | EDGAR |
| 2023-03-01 | 4 | uniQure N.V. (QURE) | Sale (S): 384 @ $19.97 | EDGAR |
| 2023-01-20 | 4 | uniQure N.V. (QURE) | Option exercise (M): 6,000 @ $5.37 · Sale (S): 6,000 @ $22.59 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2022-12-15 | 4 | uniQure N.V. (QURE) | Option exercise (M): 3,000 @ $5.37 · Sale (S): 3,000 @ $23.45 · Option exercise (M): 3,800 · Sale (S): 3,800 @ $23.43 · Option exercise (M): 3,000 (derivative) @ $0 · Option exercise (M): 3,800 (derivative) @ $0 | EDGAR |
| 2022-12-01 | 4 | uniQure N.V. (QURE) | Option exercise (M): 6,200 · Sale (S): 6,200 @ $25.38 · Option exercise (M): 6,200 (derivative) @ $0 | EDGAR |
| 2022-06-17 | 4 | uniQure N.V. (QURE) | Grant/award (A): 9,080 @ $0 · Grant/award (A): 17,810 (derivative) @ $0 | EDGAR |
| 2022-05-26 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 13,440 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | uniQure N.V. (QURE) | Sale (S): 596 @ $16.87 | EDGAR |
| 2022-02-28 | 4 | uniQure N.V. (QURE) | Grant/award (A): 1,534 @ $0 · Grant/award (A): 2,645 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 5,369 (derivative) @ $0 | EDGAR |
| 2021-03-04 | 4 | uniQure N.V. (QURE) | Sale (S): 504 @ $37.60 | EDGAR |
| 2021-03-01 | 4 | uniQure N.V. (QURE) | Grant/award (A): 2,382 @ $0 · Grant/award (A): 4,107 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-25 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1692444 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs